{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:50:56Z","timestamp":1770983456673,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier","isbn-type":[{"value":"9780443295485","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.vh.2024.08.002","type":"book-chapter","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T22:43:35Z","timestamp":1725057815000},"page":"99-124","source":"Crossref","is-referenced-by-count":1,"title":["Higher thyroid hormone levels and cancer"],"prefix":"10.1016","member":"78","reference":[{"issue":"5","key":"10.1016\/bs.vh.2024.08.002_bib1","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.urolonc.2010.07.015","article-title":"The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study","volume":"30","author":"Baldazzi","year":"2012","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"issue":"7","key":"10.1016\/bs.vh.2024.08.002_bib2","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/en.2005-0102","article-title":"Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis","volume":"146","author":"Bergh","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2024.08.002_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2020.05.011","article-title":"Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer","volume":"135","author":"Berghoff","year":"2020","journal-title":"European Journal of Cancer (Oxford, England: 1990)"},{"issue":"6","key":"10.1016\/bs.vh.2024.08.002_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/er.2012-1030","article-title":"Radioiodine therapy in benign thyroid diseases: Effects, side effects, and factors affecting therapeutic outcome","volume":"33","author":"Bonnema","year":"2012","journal-title":"Endocrine Reviews"},{"issue":"4","key":"10.1016\/bs.vh.2024.08.002_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/thy.2012.0500","article-title":"Graves\u2019 disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: A Danish population-based register study","volume":"23","author":"Brandt","year":"2013","journal-title":"Thyroid: Official Journal of the American Thyroid Association"},{"issue":"4","key":"10.1016\/bs.vh.2024.08.002_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12032-017-0928-z","article-title":"Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients","volume":"34","author":"Buda-Nowak","year":"2017","journal-title":"Medical Oncology (Northwood, London, England)"},{"issue":"11","key":"10.1016\/bs.vh.2024.08.002_bib7","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1007\/s00259-023-06274-5","article-title":"The EANM guideline on radioiodine therapy of benign thyroid disease","volume":"50","author":"Campenn\u00ec","year":"2023","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"10.1016\/bs.vh.2024.08.002_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1530\/EJE-17-0197","article-title":"Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer","volume":"177","author":"Chan","year":"2017","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/er.2018-00006","article-title":"Endocrine toxicity of cancer immunotherapy targeting immune checkpoints","volume":"40","author":"Chang","year":"2019","journal-title":"Endocrine Reviews"},{"issue":"9","key":"10.1016\/bs.vh.2024.08.002_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1016\/bs.vh.2024.08.002_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/10428190802165946","article-title":"Association of thyroid disease and thyroid autoimmunity with multiple myeloma risk: A case\u2013control study","volume":"49","author":"Dalamaga","year":"2008","journal-title":"Leukemia & Lymphoma"},{"issue":"11","key":"10.1016\/bs.vh.2024.08.002_bib12","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.RES.0000130784.90237.4a","article-title":"Proangiogenic action of thyroid hormone is fibroblast growth factor\u2013dependent and is initiated at the cell surface","volume":"94","author":"Davis","year":"2004","journal-title":"Circulation Research"},{"issue":"5","key":"10.1016\/bs.vh.2024.08.002_bib13","first-page":"1713","article-title":"Thyroid function in breast cancer patients","volume":"30","author":"Ditsch","year":"2010","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1016\/bs.vh.2024.08.002_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00008390-200112000-00010","article-title":"Autoimmunity and hypothyroidism in patients with uveal melanoma","volume":"11","author":"Ellerhorst","year":"2001","journal-title":"Melanoma Research"},{"issue":"8","key":"10.1016\/bs.vh.2024.08.002_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nature Reviews. Genetics"},{"issue":"13","key":"10.1016\/bs.vh.2024.08.002_bib16","doi-asserted-by":"crossref","first-page":"11038","DOI":"10.18632\/oncotarget.3566","article-title":"Low thyroid hormone levels improve survival in murine model for ocular melanoma","volume":"6","author":"Fabian","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/bs.vh.2024.08.002_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/1744666X.2021.1974297","article-title":"Recent insights into the pathogenesis of autoimmune hypophysitis","volume":"17","author":"Frasca","year":"2021","journal-title":"Expert Review of Clinical Immunology"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70892-4","article-title":"Decreased expression of the thyroid hormone-inactivating enzyme type 3 deiodinase is associated with lower survival rates in breast cancer","volume":"10","author":"Goemann","year":"2020","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.vh.2024.08.002_bib19","first-page":"99","article-title":"Thyroid disorders in the oncology patient","volume":"6","author":"Hartmann","year":"2015","journal-title":"Journal of the Advanced Practitioner in Oncology"},{"issue":"2","key":"10.1016\/bs.vh.2024.08.002_bib20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1055-9965.EPI-08-0911","article-title":"Thyroid function and cancer risk: A prospective population study","volume":"18","author":"Hellevik","year":"2009","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"issue":"3","key":"10.1016\/bs.vh.2024.08.002_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/EJE-09-0566","article-title":"Decreased serum TSH levels are not associated with mortality in the adult northeast German population","volume":"162","author":"Ittermann","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2024.08.002_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2019.05.015","article-title":"Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders","volume":"141","author":"Jannin","year":"2019","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"8","key":"10.1016\/bs.vh.2024.08.002_bib23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/thy.2017.0063","article-title":"Hyperthyroidism, hypothyroidism, and cause-specific mortality in a large cohort of women","volume":"27","author":"Journy","year":"2017","journal-title":"Thyroid: Official Journal of the American Thyroid Association"},{"issue":"12","key":"10.1016\/bs.vh.2024.08.002_bib24","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/jc.2016-2104","article-title":"Thyroid function and cancer risk: The Rotterdam study","volume":"101","author":"Khan","year":"2016","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"12","key":"10.1016\/bs.vh.2024.08.002_bib25","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/ijc.32283","article-title":"Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study","volume":"145","author":"Kim","year":"2019","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1016\/bs.vh.2024.08.002_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1530\/EJE-20-1123","article-title":"Opposing effects of thyroid hormones on cancer risk: A population-based study","volume":"184","author":"Krashin","year":"2021","journal-title":"European Journal of Endocrinology"},{"issue":"11","key":"10.1016\/bs.vh.2024.08.002_bib27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/ERC-21-0187","article-title":"Pre-diagnosis thyroid hormone dysfunction is associated with cancer mortality","volume":"28","author":"Krashin","year":"2021","journal-title":"Endocrine-Related Cancer"},{"issue":"5","key":"10.1016\/bs.vh.2024.08.002_bib28","first-page":"363","article-title":"Hyperthyroidism: Diagnosis and treatment","volume":"93","author":"Kravets","year":"2016","journal-title":"American Family Physician"},{"issue":"2","key":"10.1016\/bs.vh.2024.08.002_bib29","first-page":"184","article-title":"Thyroid hormone receptors: Multiple forms, multiple possibilities","volume":"14","author":"Lazar","year":"1993","journal-title":"Endocrine Reviews"},{"issue":"4","key":"10.1016\/bs.vh.2024.08.002_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.pcan.4500542","article-title":"Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer","volume":"4","author":"Lehrer","year":"2001","journal-title":"Prostate Cancer and Prostatic Diseases"},{"issue":"6","key":"10.1016\/bs.vh.2024.08.002_bib31","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0022-5347(05)64161-4","article-title":"Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia","volume":"168","author":"Lehrer","year":"2002","journal-title":"The Journal of Urology"},{"issue":"2","key":"10.1016\/bs.vh.2024.08.002_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5603\/EP.a2022.0020","article-title":"Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: A meta-analysis","volume":"73","author":"Lei","year":"2022","journal-title":"Endokrynologia Polska"},{"issue":"8","key":"10.1016\/bs.vh.2024.08.002_bib33","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1096\/fj.12-227132","article-title":"Nuclear monomeric integrin \u03b1v in cancer cells is a coactivator regulated by thyroid hormone","volume":"27","author":"Lin","year":"2013","journal-title":"The FASEB Journal"},{"issue":"5","key":"10.1016\/bs.vh.2024.08.002_bib34","first-page":"C980","article-title":"L-Thyroxine vs. 3,5,3\u2019-triiodo-L-thyronine and cell proliferation: Activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"296","author":"Lin","year":"2009","journal-title":"American Journal of"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1098-2744(199909)26:1<53::AID-MC7>3.0.CO;2-Z","article-title":"Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells","volume":"26","author":"Lin","year":"1999","journal-title":"Molecular Carcinogenesis"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2196088","article-title":"Thyroid hormones as biomarkers of lung cancer: A retrospective study","volume":"55","author":"Ma","year":"2023","journal-title":"Annals of Medicine"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.21873\/anticanres.15480","article-title":"Thyroid hormones and morphological features of primary breast cancer","volume":"42","author":"Meirovitz","year":"2022","journal-title":"Anticancer Research"},{"issue":"Suppl 1","key":"10.1016\/bs.vh.2024.08.002_bib38","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1756-6614-4-S1-S6","article-title":"Transcriptional regulation by nonclassical action of thyroid hormone","volume":"4","author":"Moeller","year":"2011","journal-title":"Thyroid Research"},{"issue":"12","key":"10.1016\/bs.vh.2024.08.002_bib39","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1210\/me.2004-0542","article-title":"Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1\u03b1 and glycolytic genes","volume":"19","author":"Moeller","year":"2005","journal-title":"Molecular Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86754-6","article-title":"Thyroid hormone receptor \u03b11 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor","volume":"11","author":"Mohamed","year":"2021","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.vh.2024.08.002_bib41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.21873\/anticanres.14848","article-title":"Elevated free triiodothyronine is associated with increased proliferative activity in triple-negative breast cancer","volume":"41","author":"Nisman","year":"2021","journal-title":"Anticancer Research"},{"issue":"4","key":"10.1016\/bs.vh.2024.08.002_bib42","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.21873\/anticanres.14199","article-title":"Association of triiodothyronine levels with prostate cancer histopathological differentiation and tumor stage","volume":"40","author":"Ov\u010dari\u010dek","year":"2020","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.vh.2024.08.002_bib43","first-page":"1","article-title":"Thyroid dysfunctions induced by molecular cancer therapies: A synopsis for nuclear medicine thyroidologists","volume":"2021","author":"Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3","key":"10.1016\/bs.vh.2024.08.002_bib44","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00259-020-05018-z","article-title":"Higher thyroid hormone levels and cancer","volume":"48","author":"Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"5","key":"10.1016\/bs.vh.2024.08.002_bib45","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3390\/curroncol31050176","article-title":"The significance of thyroid hormone receptors in breast cancer: A hypothesis-generating narrative review","volume":"31","author":"Quan","year":"2024","journal-title":"Current Oncology (Toronto, Ont.)"},{"issue":"6","key":"10.1016\/bs.vh.2024.08.002_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00345-010-0627-2","article-title":"Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib","volume":"29","author":"Riesenbeck","year":"2011","journal-title":"World Journal of Urology"},{"issue":"10","key":"10.1016\/bs.vh.2024.08.002_bib47","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid: Official Journal of the American Thyroid Association"},{"issue":"7","key":"10.1016\/bs.vh.2024.08.002_bib48","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40618-018-0984-z","article-title":"Endocrine and metabolic adverse effects of immune checkpoint inhibitors: An overview (what endocrinologists should know)","volume":"42","author":"Ruggeri","year":"2019","journal-title":"Journal of Endocrinological Investigation"},{"issue":"11","key":"10.1016\/bs.vh.2024.08.002_bib49","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1007\/s40618-023-02096-2","article-title":"Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center","volume":"46","author":"Ruggeri","year":"2023","journal-title":"Journal of Endocrinological Investigation"},{"issue":"2","key":"10.1016\/bs.vh.2024.08.002_bib50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mcna.2012.01.003","article-title":"Subacute, silent, and postpartum thyroiditis","volume":"96","author":"Samuels","year":"2012","journal-title":"The Medical Clinics of North America"},{"issue":"2","key":"10.1016\/bs.vh.2024.08.002_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/cen.14130","article-title":"Diagnostic testing for Graves\u2019 or non-Graves\u2019 hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography","volume":"92","author":"Scappaticcio","year":"2020","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"10.1016\/bs.vh.2024.08.002_bib52","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/cncr.25422","article-title":"Hypothyroidism in patients with renal cell carcinoma","volume":"117","author":"Schmidinger","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/bs.vh.2024.08.002_bib53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/bs.vh.2024.08.002_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-15-0989","article-title":"Hypothyroidism and hyperthyroidism and breast cancer risk: A nationwide cohort study","volume":"174","author":"S\u00f8gaard","year":"2016","journal-title":"European Journal of Endocrinology"},{"issue":"10","key":"10.1016\/bs.vh.2024.08.002_bib55","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1158\/1055-9965.EPI-20-0283","article-title":"Abnormal and euthyroid ranges of thyroid hormones in serum and liver cancer mortality: A Cohort study","volume":"29","author":"Sohn","year":"2020","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010246","article-title":"Management of endocrine and metabolic toxicities of immune-checkpoint inhibitors: From clinical studies to a real-life scenario","volume":"15","author":"Spagnolo","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/bs.vh.2024.08.002_bib57","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.21037\/tcr-23-2164","article-title":"Development of a prediction model for the association between thyroid dysfunction and breast cancer","volume":"13","author":"Tang","year":"2024","journal-title":"Translational Cancer Research"},{"issue":"9","key":"10.1016\/bs.vh.2024.08.002_bib58","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/ijc.27470","article-title":"Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk","volume":"131","author":"Tosovic","year":"2012","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1016\/bs.vh.2024.08.002_bib59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/EJE-12-0564","article-title":"Triiodothyronine levels in relation to mortality from breast cancer and all causes: A population-based prospective cohort study","volume":"168","author":"Tosovic","year":"2013","journal-title":"European Journal of Endocrinology"},{"issue":"3","key":"10.1016\/bs.vh.2024.08.002_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2587","article-title":"Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women","volume":"12","author":"Tosovic","year":"2010","journal-title":"Breast Cancer Research"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib61","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/1471-2407-14-536","article-title":"T3 levels in relation to prognostic factors in breast cancer: A population-based prospective cohort study","volume":"14","author":"Tosovic","year":"2014","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/bs.vh.2024.08.002_bib62","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1210\/jc.2010-2693","article-title":"The thyroid epidemiology, audit, and research study (TEARS): Morbidity in patients with endogenous subclinical hyperthyroidism","volume":"96","author":"Vadiveloo","year":"2011","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/bs.vh.2024.08.002_bib63","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/1078-0432.CCR-20-2647","article-title":"Exogenous thyroid hormone is associated with shortened survival and upregulation of high-risk gene expression profiles in steroid receptor-positive breast cancers","volume":"27","author":"Wahdan-Alaswad","year":"2021","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib64","article-title":"Does hypothyroidism increase the risk of breast cancer: Evidence from a meta-analysis","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/bs.vh.2024.08.002_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01690-y","article-title":"Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors","volume":"18","author":"Yang","year":"2020","journal-title":"BMC Medicine"},{"issue":"7","key":"10.1016\/bs.vh.2024.08.002_bib66","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0033-1341474","article-title":"Hyperthyroidism and thyroid cancer risk: A population-based cohort study","volume":"121","author":"Yeh","year":"2013","journal-title":"Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association"},{"issue":"3","key":"10.1016\/bs.vh.2024.08.002_bib67","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiological Reviews"},{"issue":"7","key":"10.1016\/bs.vh.2024.08.002_bib68","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1210\/jc.2013-3832","article-title":"Thyroid hormones and mortality risk in euthyroid individuals: The Kangbuk Samsung health study","volume":"99","author":"Zhang","year":"2014","journal-title":"The Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Vitamins and Hormones","Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672924000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672924000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T16:26:59Z","timestamp":1755016019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672924000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443295485"],"references-count":68,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2024.08.002","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}